Evidence map›Paper›PMID 29865161›Full record

ReviewToxics2018

Formalin-Fixed Paraffin-Embedded Tissues-An Untapped Biospecimen for Biomonitoring DNA Adducts by Mass Spectrometry.

Byeong Hwa Yun, Jingshu Guo, Robert J Turesky

Abstract readReview
In one paragraph

Review in Toxics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pulmonary Health Effects of Indoor Volatile Organic Compounds-A Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  2. Article
  3. Indoor air pollution and airway health.The Journal of allergy and clinical immunology · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Byeong Hwa YunMasonic Cancer Center and Department of Medicinal Chemistry, University of Minnesota, 2231 6th St. SE, Minneapolis, MN 55455, USA. bhyun@umn.edu.ORCID 0000-0001-8906-1974
Jingshu GuoMasonic Cancer Center and Department of Medicinal Chemistry, University of Minnesota, 2231 6th St. SE, Minneapolis, MN 55455, USA. guoj@umn.edu.ORCID 0000-0001-8987-6911
Robert J TureskyMasonic Cancer Center and Department of Medicinal Chemistry, University of Minnesota, 2231 6th St. SE, Minneapolis, MN 55455, USA. rturesky@umn.edu.ORCID 0000-0001-7355-9903

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
SYNTHETIC & ANALYTICALP01ES004068 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · PI IDEN, CHARLES R · 1987 to 2011
$14.1M
Chemical markers of heterocyclic aromatic amines for human biomonitoringR01CA122320 · NCI · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2007 to 2018
$4.8M
DNA adductomics of the urinary systemR01CA220367 · NCI · UNIVERSITY OF MINNESOTA · PI ROSENQUIST, THOMAS A, TURESKY, ROBERT J. · 2017 to 2022
$3.0M
New biomonitoring methodologies to measure DNA adducts in human tissuesR01ES019564 · NIEHS · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2011 to 2020
$2.8M
Carcinogen DNA adduct biomarkers in formalin fixed tissuesR33CA186795 · NCI · UNIVERSITY OF MINNESOTA · PI TURESKY, ROBERT J. · 2014 to 2016
$982k
Novel approach to measure DNA adducts in humansR21ES014438 · NIEHS · WADSWORTH CENTER · PI TURESKY, ROBERT J. · 2006 to 2007
$356k
NCATS NIH HHS UL1 TR000114NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA122320NCI NIH HHS R01 CA220367NCI NIH HHS R33 CA186795NIEHS NIH HHS P01 ES004068NIEHS NIH HHS R01 ES019564NIEHS NIH HHS R21 ES014438
6 · The paper itself

Abstract

The measurement of DNA adducts provides important information about human exposure to genotoxic chemicals and can be employed to elucidate mechanisms of DNA damage and repair. DNA adducts can serve as biomarkers for interspecies comparisons of the biologically effective dose of procarcinogens and permit extrapolation of genotoxicity data from animal studies for human risk assessment. One major challenge in DNA adduct biomarker research is the paucity of fresh frozen biopsy samples available for study. However, archived formalin-fixed paraffin-embedded (FFPE) tissues with clinical diagnosis of disease are often available. We have established robust methods to recover DNA free of crosslinks from FFPE tissues under mild conditions which permit quantitative measurements of DNA adducts by liquid chromatography-mass spectrometry. The technology is versatile and can be employed to screen for DNA adducts formed with a wide range of environmental and dietary carcinogens, some of which were retrieved from section-cuts of FFPE blocks stored at ambient temperature for up to nine years. The ability to retrospectively analyze FFPE tissues for DNA adducts for which there is clinical diagnosis of disease opens a previously untapped source of biospecimens for molecular epidemiology studies that seek to assess the causal role of environmental chemicals in cancer etiology.

Indexed as

biomarkerbiomonitoringcarcinogenDNA adductsformalin-fixed paraffin-embedded tissuesmass spectrometry

Identifiers

PMID29865161
PMCPMC6027047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.